<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>General Practice</title>
<link>http://hdl.handle.net/10468/77</link>
<description/>
<pubDate>Mon, 20 May 2013 00:33:17 GMT</pubDate>
<dc:date>2013-05-20T00:33:17Z</dc:date>
<item>
<title>Self-care coping strategies in people with diabetes: a qualitative exploratory study</title>
<link>http://hdl.handle.net/10468/76</link>
<description>Self-care coping strategies in people with diabetes: a qualitative exploratory study
Collins, Margaret M.; Bradley, Colin P.; O'Sullivan, Tony; Perry, Ivan J.
Background: The management of diabetes self-care is largely the responsibility of the patient. With more emphasis on the prevention of complications, adherence to diabetes self-care regimens can be difficult. Diabetes self-care requires the patient to make many dietary and lifestyle changes. This study will explore patient perceptions of diabetes self-care, with particular reference to the burden of self-care and coping strategies among patients.&#13;
Methods: A maximum variation sample of 17 patients was selected from GP practices and diabetes clinics in Ireland to include patients with types 1 and 2 diabetes, various self-care regimens, and a range of diabetes complications. Data were collected by in-depth interviews; which were tape-recorded and transcribed. The transcripts were analysed using open and axial coding procedures to identify main categories, and were reviewed by an independent corroborator. Discussion of the results is made in the theoretical context of the health belief, health value, self-efficacy, and locus of control frameworks.&#13;
Results: Patients' perceptions of their self-care varied on a spectrum, displaying differences in self-care responsibilities such as competence with dietary planning, testing blood sugar and regular exercise. Three patient types could be distinguished, which were labeled: "proactive manager," a patient who independently monitors blood glucose and adjusts his/her self-care regime to maintain metabolic control; "passive follower," a patient who follows his/her prescribed self-care regime, but does not react autonomously to changes in metabolic control; and "nonconformist," a patient who does not follow most of his/her prescribed self-care regimen.&#13;
Conclusion: Patients have different diabetes self-care coping strategies which are influenced by their self-care health value and consequently may affect their diet and exercise choices, frequency of blood glucose monitoring, and compliance with prescribed medication regimens. Particular attention should be paid to the patient's self-care coping strategy, and self-care protocols should be tailored to complement the different patient types.
</description>
<pubDate>Fri, 20 Feb 2009 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10468/76</guid>
<dc:date>2009-02-20T00:00:00Z</dc:date>
</item>
<item>
<title>Reactions to treatment debriefing among the participants of a placebo controlled trial</title>
<link>http://hdl.handle.net/10468/248</link>
<description>Reactions to treatment debriefing among the participants of a placebo controlled trial
Di Blasi, Zelda; Crawford, Fay; Bradley, Colin P.; Kleijnen, Jos
BACKGROUND: A significant proportion of trial participants respond to placebos for a variety of conditions. Despite the common conduct of these trials and the strong emphasis placed on informed consent, very little is known about informing participants about their individual treatment allocation at trial closure. This study aims to address this gap in the literature by exploring treatment beliefs and reactions to feedback about treatment allocation in the participants of a placebo-controlled randomized clinical trial (RCT). METHODS: Survey of trial participants using a semi-structured questionnaire including close and open-ended questions administered as telephone interviews and postal questionnaires. Trial participants were enrolled in a double-blind placebo-controlled RCT evaluating the effectiveness of corticosteroid for heel pain (ISRCTN36539116). The trial had closed and participants remained blind to treatment allocation. We assessed treatment expectations, the percentage of participants who wanted to be informed about their treatment allocation, their ability to guess and reactions to debriefing. RESULTS: Forty-six (73%) contactable participants responded to our survey. Forty-two were eligible (four participants with bilateral disease were excluded as they had received both treatments). Most (79%) participants did not have any expectations prior to receiving treatment, but many 'hoped' that something would help. Reasons for not having high expectations included the experimental nature of their care and possibility that they may get a placebo. Participants were hopeful because their pain was so severe and because they trusted the staff and services. Most (83%) wanted to be informed about their treatment allocation and study results. Over half (55%) said they could not guess which treatment they had been randomized to, and many of those who attempted a guess were incorrect. Reactions to treatment debriefing were generally positive, including in placebo responders. CONCLUSION: Our study suggests that most trial participants want to be informed about their treatment allocation and trial results. Further research is required to develop measure of hope and expectancy and to rigorously evaluate the effects of debriefing prospectively.
</description>
<pubDate>Fri, 22 Apr 2005 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10468/248</guid>
<dc:date>2005-04-22T00:00:00Z</dc:date>
</item>
</channel>
</rss>
